[Aldactone therapy in ambulatory patients with exertion-induced cardiorespiratory insufficiency. Preliminary report].
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects*; D005082:Physical Exertion; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*
D013148:Spironolactone
Zur Aldactone-Therapie bei ambulanten Patienten mit kardiorespiratorischer Belastungsinsuffizienz. Vorläufige Mitteilung